Clinical trial
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative…
NCT00259571 · Heidelberg University, Other · Withdrawn
Key facts
| NCT number | NCT00259571 |
|---|---|
| Title | Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. |
| Official title | Prospektive, Randomisierte, Doppelblinde, Mesalazin-kontrollierte ("Double-dummy Verfahren) Multizenter-Studie Zur Beurteilung Der Annahme Der äquivalenten Wirkung Von Intestinal Retardiert Freigesetztem Phosphatidylcholin gegenüber Mesalazin (Non-inferiority Study) in Der Remissionserhaltung Der… |
| Lead sponsor | Heidelberg University, Other |
| Collaborators | Dietmar Hopp Stiftung |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | retarded release phosphatidylcholine |
| Enrollment | 0 |
| Completion | Mar 1, 2010 |
| First posted | Nov 29, 2005 |
| Last update posted | Dec 13, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: